Toxicological Review of Perfluorodecanoic Acid (Pfda) (Interagency Science Consultation Draft, 2022)
Citation:
U.S. EPA. Toxicological Review of Perfluorodecanoic Acid (Pfda) (Interagency Science Consultation Draft, 2022). U.S. Environmental Protection Agency, Washington, DC, EPA/635/R-22/004a, 2022.
Impact/Purpose:
This document presents a draft assessment plan for the PFDA assessment that will be the subject of an SAB/Chemical Assessment Advisory Committee review which will define the scope and approach of the IRIS assessment for this chemical.
Description:
In April 2023, the draft Toxicological Review of Perfluorodecanoic Acid (PFDA) and Related Salts and the draft charge to external peer reviewers were released for a 60-day public review and comment period. The Toxicological Review and charge were reviewed internally by EPA and by other federal agencies and White House Offices before public release. Consistent with the May 2009 IRIS assessment development process, all written comments on IRIS assessments submitted by other federal agencies and White House Offices are made publicly available. Accordingly, interagency comments are posted on this site.
URLs/Downloads:
1. ATSDR PFDA IASC Comments March 2022 (PDF,
7 pp,
237
KB,
about PDF)
2. DoD PFDA IASC Comments Mar 2022 (PDF,
6 pp,
99
KB,
about PDF)
3. EOP OMB PFDA IASC Comments Mar 2022 (PDF,
4 pp,
165
KB,
about PDF)
4. NIEHS PFDA IASC Comments Mar 2022 (PDF,
8 pp,
265
KB,
about PDF)
5. NIOSH PFDA IASC Comments Mar 2022 (PDF,
3 pp,
159
KB,
about PDF)
Primary Literature Search References Sorted by Author (PFDA)
Record Details:
Record Type:DOCUMENT(
IRIS ASSESSMENT)
Product Published Date:03/06/2022
Record Last Revised:04/10/2023
OMB Category:Other
Record ID:
353904
Keywords:
PFAS, IRIS, Perfluorodecanoic Acid, PFDA, IRIS Assessment, IRIS Protocol, PICO, Stakeholder, draft development, HHRA, substance_nmbr=702, 335-76-2,
latervers
future
:353958
dateprompt
:Publication
Title
:IRIS Toxicological Review of Perfluorodecanoic Acid (PFDA) (Peer Review Draft)
Version
:1.0
Version Description
:New version of EIMS record 353904
version_date
:2019-11-08
future
:354408
dateprompt
:Publication
Title
:IRIS Toxicological Review of Perfluorodecanoic Acid (PFDA) and Related Salts (Public Comment and External Review Draft)
Version
:1.0
Version Description
:New version of EIMS record 353904
version_date
:2019-11-08
Acronyms:
Title
:Toxicological Review of Perfluorodecanoic Acid (Pfda) (Interagency Science Consultation Draft, 2022)
Version
:1.0
Acronym
:EOP
Acronym Meaning
:EOP
Title
:Toxicological Review of Perfluorodecanoic Acid (Pfda) (Interagency Science Consultation Draft, 2022)
Version
:1.0
Acronym
:PFDA
Acronym Meaning
:Perfluorodecanoic Acid
Title
:Toxicological Review of Perfluorodecanoic Acid (Pfda) (Interagency Science Consultation Draft, 2022)
Version
:1.0
Acronym
:PFAS
Acronym Meaning
:Per- and Polyfluoroalkyl Substances
Title
:Toxicological Review of Perfluorodecanoic Acid (Pfda) (Interagency Science Consultation Draft, 2022)
Version
:1.0
Acronym
:ORD
Acronym Meaning
:ORD
Title
:Toxicological Review of Perfluorodecanoic Acid (Pfda) (Interagency Science Consultation Draft, 2022)
Version
:1.0
Acronym
:IASC
Acronym Meaning
:Interagency Science Consultation Draft
Title
:Toxicological Review of Perfluorodecanoic Acid (Pfda) (Interagency Science Consultation Draft, 2022)
Version
:1.0
Acronym
:HERO
Acronym Meaning
:HERO
Document IDs:
EPA Number
:EPA/635/R-22/004A